10x Genomics Clinician Researcher Accelerator Program

10x Genomics Clinician Researcher Accelerator Program

Clinical research is increasingly driven by the need to understand biological heterogeneity, identify actionable biomarkers, and link molecular mechanisms to patient outcomes. Traditional bulk and low-resolution approaches often mask clinically relevant signals, slowing discovery and translation. 10x Genomics technologies accelerate clinical research by enabling cell-resolved and spatially resolved insights at scale at earlier in the research pipeline.

A targeted Clinician Researcher Accelerator Program designed to support medically qualified clinician researchers in generating high-impact spatial and single-cell data, with dedicated support and preferential pricing to fast-track translational research.

The Clinician Researcher Accelerator Program is a limited-time initiative supporting medically qualified clinician researchers who are looking to integrate spatial transcriptomics and single-cell profiling into their research. Successful applicants will receive access to dedicated technical guidance, and preferential pricing to help generate robust pilot data for translational and clinically focused studies.

1. Resolving clinical heterogeneity at single-cell resolution

Many clinical samples including tumours, immune tissues, and biopsies, are highly heterogeneous. Bulk profiling averages signals across cell populations, obscuring rare or disease-driving cell states.

Chromium Single Cell technologies enable researchers to:

  • Identify rare or pathogenic cell populations
  • Characterise immune cell diversity and activation states
  • Study patient-to-patient variability at cellular resolution

Clinical impact:
Earlier identification of clinically relevant subpopulations improves hypothesis generation, patient stratification strategies, and biomarker discovery.

2. Linking molecular signals to tissue context

Understanding where cells are located within tissue is critical for clinical interpretation, particularly in oncology, immunology, and pathology-driven research.

Visium Spatial Gene Expression allows researchers to:

  • Map gene expression within intact tissue sections
  • Correlate molecular patterns with histology
  • Identify spatially distinct disease niches

Clinical impact:
Spatial context strengthens biological interpretation, supports translational relevance, and enables more compelling mechanistic narratives for grants and publications.

3. Translating discovery into spatial validation

Discovery technologies are most powerful when paired with targeted validation in clinically relevant samples.

Xenium In Situ enables:

  • High-plex, single-cell resolution spatial validation
  • Direct visualisation of clinically relevant gene signatures
  • Confirmation of biomarkers within preserved tissue architecture

Clinical impact:
Xenium supports the transition from discovery to validation which is a critical step for translational studies, diagnostic development, and clinical adoption.

4. Accelerating the path from pilot data to funding

Clinical research is often constrained by:

  • Limited sample availability
  • Ethical and governance considerations
  • The need to justify scale and cost upfront

10x Genomics platforms are well suited to small, high-information pilot studies, allowing researchers to:

  • De-risk experimental design
  • Generate convincing preliminary data
  • Strengthen ARC, NHMRC, and translational grant applications

Clinical impact:
High-quality pilot data reduces uncertainty and accelerates progression to larger, funded studies.

5. Enabling multi-modal clinical insights

Complex clinical questions rarely have single-dimensional answers.

10x Genomics workflows support:

  • Integration of transcriptomics, immune profiling, and spatial biology
  • Cross-platform studies linking cell state, location, and function
  • More comprehensive biological models of disease

Clinical impact:
Multi-modal data improves robustness, reproducibility, and translational relevance which is increasingly expected by reviewers and collaborators.

6. Supporting reproducibility and scalability in clinical settings

Clinical research demands consistency, robustness, and scalability.

10x Genomics technologies are:

  • Highly standardised and widely adopted
  • Supported by validated workflows and protocols
  • Designed for reproducible data generation across sites

Clinical impact:
Standardisation supports multi-centre studies and facilitates collaboration between hospitals, academia, and industry.

Apply for the Clinician Researcher Accelerator Program now!

  • One winner will be awarded 50% discount across Xenium v1 or 5k Prime panel*(2 slides) and Xenium running consumables Or One Flex kit (16-sample configuration)
  • All approved applicants will receive a 25% discount
  • Orders must be placed by 19 June 2026

*Custom panels excluded.

Application timeline
• Applications close: 27 May 2026
• Outcome notification: 1 June 2026

Fill in the form below to submit your application now!

2026 Millennium Science – 10x Genomics Fellowship Program

Special focus edition: FFPE

Who This Fellowship Is For

Graduate students and early to mid-career researchers with no prior hands-on experience using 10x Genomics technologies are invited to apply for the prestigious 2026 Millennium Science – 10x Genomics Fellowship Program.
This Fellowship is designed to support researchers who are keen to adopt cutting-edge single-cell and spatial technologies in their work.

Important Dates

Applications close: 16 March 2026
Outcomes announced: 30 March 2026

Fellowship Focus: FFPE Samples

The 2026 Fellowship Program focuses on the application of 10x Genomics technologies to FFPE samples, using one or more of the following platforms:
Chromium Single Cell
Visium Spatial 
Xenium In Situ  (NEW within the Fellowship Program!)

Fellowship Benefits

Successful applicants will receive:

  • A personalised mentoring session on experimental design with a 10x Genomics specialist
  • Dedicated support from the Fellowship Program Coordinator
  • 10x Chromium or Visium CytAssist demo instrument placement (if required and subject to availability)
  • Support with project onboarding through a core facility running 10x Genomics platforms (Chromium, Visium or Xenium)
  • Discounted 10x Genomics consumables*
  • Invitation to present at Millennium Science–10x Genomics events
  • Membership in the Millennium Science–10x Genomics Fellows Network
  • Fellowship-exclusive merchandise
  • A certificate confirming completion of the Fellowship Program

Applications will be assessed by a panel of scientific experts from Millennium Science and 10x Genomics, based on project innovation, feasibility, and potential to inspire future research.
Through this program, Millennium Science and 10x Genomics aim to empower early and mid-career researchers to generate high-quality pilot data using advanced multi-omics technologies, supporting future experimental design and funding applications.
*Please note, the Fellowship is not associated with provision of free reagents. Discounts cannot be combined with other promotions.

Application Details

To apply, please submit:

  • Project title: 20 words maximum
  • Abstract: 250 words maximum
  • CV: Attach 1-page CV
  • Letter of Support: Please provide a letter of support from the principal investigator of the laboratory. Additional institutional or departmental letters of reference may be submitted to support the application.

Completion of the online application survey below is required to submit your application.

Applications will be reviewed by Millennium Science as they are being received. Successful applicants will be notified via email.

Conditions of Eligibility

  • No previous personal experience using 10x Genomics technologies
  • Open to graduate students and early to mid-career researchers (up to 15 years post-PhD; special circumstances may be considered with supporting documentation)
  • Selected candidates must complete the specified individualised training program prior to reagent delivery or instrument placement
  • Applicants must be based in Australia or New Zealand

Hear from Our 10x Genomics Fellowship Alumni

“I was fortunate to receive the Millennium Science-10x Genomics Fellowship in 2021 during my first postdoctoral appointment in Associate Professor Megan Wilson’s lab at the Department of Anatomy, University of Otago, where her lab studies whole-body regeneration in the marine tunicate Botrylloides diegensis. At a time when single-cell technologies were still emerging, the Fellowship enabled us to rapidly adopt 10x Genomic technology and interrogate this process at unprecedented resolution. After some optimisation, our first 10x run produced a high-quality dataset that underpinned a recent publication in Development. Importantly, the Fellowship established long-term single-cell capability in the lab, directly benefiting lab member Berivan Temiz, who applied this method extensively during her PhD. I continue to find 10x Genomics the most user-friendly and straightforward to implement.” Michael Meier

“I moved to Melbourne in 2015 from Phuket, Thailand to pursue my passion for biomedical science. I completed my PhD at Monash University in 2023,investigating how epigenetic mechanisms shape B-cell biology, particularly the role of the histone methyltransferase DOT1L in regulating immune cell identity and function. My research is driven by a desire to understand how immune cells adapt in different disease contexts and how gene regulation disruptions contribute to chronic inflammatory conditions. In early 2023, I was honoured to receive the Millennium Science-10x Genomics Fellowship, which has been pivotal in advancing this work. With their support, I implemented single-cell multiome sequencing to profile circulating B cells from individuals with chronic disease, including Long COVID-a debilitating, multi-system syndrome that remains poorly understood. By measuring gene expression and chromatin accessibility in the same cell, this approach reveals subtle immune signatures and hidden cellular states, opening new avenues for diagnosis and treatment. The Fellowship provided not only advanced technology, but also personalised mentorship, technical guidance, and connection to a collaborative network of fellows across Australia and New Zealand. This support has accelerated my research and positioned me to tackle ambitious questions about immune dysfunction in complex diseases like Long COVID.” Liam Kealy

2026 Information Session

Any questions?

If you have any questions, please contact us at fellowship@mscience.com.au.